BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35331276)

  • 1. The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ).
    Francisco R; Brasil S; Pascoal C; Jaeken J; Liddle M; Videira PA; Dos Reis Ferreira V
    Orphanet J Rare Dis; 2022 Mar; 17(1):134. PubMed ID: 35331276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stakeholders' views on drug development: the congenital disorders of glycosylation community perspective.
    Monticelli M; Francisco R; Brasil S; Marques-da-Silva D; Rijoff T; Pascoal C; Jaeken J; Videira PA; Dos Reis Ferreira V
    Orphanet J Rare Dis; 2022 Jul; 17(1):303. PubMed ID: 35907899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals.
    Pascoal C; Ferreira I; Teixeira C; Almeida E; Slade A; Brasil S; Francisco R; Ligezka AN; Morava E; Plotkin H; Jaeken J; Videira PA; Barros L; Dos Reis Ferreira V
    Orphanet J Rare Dis; 2022 Oct; 17(1):398. PubMed ID: 36309700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation.
    de Freitas C; Dos Reis V; Silva S; Videira PA; Morava E; Jaeken J
    BMC Health Serv Res; 2017 Sep; 17(1):682. PubMed ID: 28950866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Participatory Framework for Plain Language Clinical Management Guideline Development.
    Francisco R; Alves S; Gomes C; Granjo P; Pascoal C; Brasil S; Neves A; Santos I; Miller A; Krasnewich D; Morava E; Lam C; Jaeken J; Videira PA; Dos Reis Ferreira V
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36294089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach.
    Francisco R; Pascoal C; Marques-da-Silva D; Brasil S; Pimentel-Santos FM; Altassan R; Jaeken J; Grosso AR; Dos Reis Ferreira V; Videira PA
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32635232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Community-Based Participatory Framework to Co-Develop Patient Education Materials (PEMs) for Rare Diseases: A Model Transferable across Diseases.
    Falcão M; Allocca M; Rodrigues AS; Granjo P; Francisco R; Pascoal C; Rossi MG; Marques-da-Silva D; Magrinho SCM; Jaeken J; Castro LA; de Freitas C; Videira PA; de Andrés-Aguayo L; Dos Reis Ferreira V
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Electronic Questionnaire for Liver Assessment in Congenital Disorders of Glycosylation (LeQCDG): A Patient-Centered Study.
    Marques-da-Silva D; Francisco R; Dos Reis Ferreira V; Forbat L; Lagoa R; Videira PA; Witters P; Jaeken J; Cassiman D
    JIMD Rep; 2019; 44():55-64. PubMed ID: 30008170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resilience in patients and family caregivers living with congenital disorders of glycosylation (CDG): a quantitative study using the brief resilience coping scale (BRCS).
    Poejo J; Gomes AI; Granjo P; Dos Reis Ferreira V
    Orphanet J Rare Dis; 2024 Mar; 19(1):98. PubMed ID: 38439013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel approach to conducting clinical trials in the community setting: utilizing patient-driven platforms and social media to drive web-based patient recruitment.
    Applequist J; Burroughs C; Ramirez A; Merkel PA; Rothenberg ME; Trapnell B; Desnick RJ; Sahin M; Krischer JP
    BMC Med Res Methodol; 2020 Mar; 20(1):58. PubMed ID: 32169041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis Study.
    Applequist J; Burroughs C; Merkel PA; Rothenberg M; Trapnell B; Desnick R; Sahin M; Krischer J
    J Med Internet Res; 2023 Mar; 25():e39262. PubMed ID: 36917158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation.
    Francisco R; Brasil S; Pascoal C; Edmondson AC; Jaeken J; Videira PA; de Freitas C; Ferreira VDR; Marques-da-Silva D
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.
    Starosta RT; Boyer S; Tahata S; Raymond K; Lee HE; Wolfe LA; Lam C; Edmondson AC; Schwartz IVD; Morava E
    Orphanet J Rare Dis; 2021 Jan; 16(1):20. PubMed ID: 33413482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital disorders of glycosylation (CDG): Quo vadis?
    Péanne R; de Lonlay P; Foulquier F; Kornak U; Lefeber DJ; Morava E; Pérez B; Seta N; Thiel C; Van Schaftingen E; Matthijs G; Jaeken J
    Eur J Med Genet; 2018 Nov; 61(11):643-663. PubMed ID: 29079546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG).
    Brasil S; Allocca M; Magrinho SCM; Santos I; Raposo M; Francisco R; Pascoal C; Martins T; Videira PA; Pereira F; Andreotti G; Jaeken J; Kantautas KA; Perlstein EO; Ferreira VDR
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of N-glycosylation (CDG).
    Casetta B; Malvagia S; Funghini S; Martinelli D; Dionisi-Vici C; Barone R; Fiumara A; Donati MA; Guerrini R; la Marca G
    Clin Chem Lab Med; 2020 Aug; 59(1):165-171. PubMed ID: 32776892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.
    Al Teneiji A; Bruun TU; Sidky S; Cordeiro D; Cohn RD; Mendoza-Londono R; Moharir M; Raiman J; Siriwardena K; Kyriakopoulou L; Mercimek-Mahmutoglu S
    Mol Genet Metab; 2017 Mar; 120(3):235-242. PubMed ID: 28122681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Different Recruitment Methods: Longitudinal, Web-Based, Pan-European Physical Activity Through Sustainable Transport Approaches (PASTA) Project.
    Gaupp-Berghausen M; Raser E; Anaya-Boig E; Avila-Palencia I; de Nazelle A; Dons E; Franzen H; Gerike R; Götschi T; Iacorossi F; Hössinger R; Nieuwenhuijsen M; Rojas-Rueda D; Sanchez J; Smeds E; Deforth M; Standaert A; Stigell E; Cole-Hunter T; Int Panis L
    J Med Internet Res; 2019 Mar; 21(5):e11492. PubMed ID: 31066715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruiting Participants for Population Health Intervention Research: Effectiveness and Costs of Recruitment Methods for a Cohort Study.
    Wasfi R; Poirier Stephens Z; Sones M; Laberee K; Pugh C; Fuller D; Winters M; Kestens Y
    J Med Internet Res; 2021 Nov; 23(11):e21142. PubMed ID: 34587586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
    Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.